Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort.
Kathryn C FitzgeraldAnne DamianDevon S ConwayEllen M MowryPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Increased vascular comorbidity burden was associated with clinical and imaging markers of neurologic dysfunction and neurodegeneration in MS. Strategies to optimize comorbidity management in people with MS are warranted.